ARRAN PHARMACY LIMITED
- · Thesis: well-run, low negotiation leverage
Opportunity 82/100 (exceptional), bankability 80/100. Strong seller-intent signal (83/100, director aged 72). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Cash flow review and working-capital discipline. Cash down -92% YoY — forensic review of receivables, stock turns, and creditor days. Most likely exit: strategic trade sale (73/100).
Refinance opportunity
1 live charge · oldest 24.2y
Refinance would be pressure-driven, not opportunity-driven. Expect tighter margins and covenant scrutiny.
- · Oldest live charge is 24.2 years old — likely at or near maturity.
- · Single lender — cleanest path to refinance.
- · Cashflow trend is negative — lender view likely cautious.
Data confidence
Overall: medium (77/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total assets | £405.1k | £418.8k |
| Current assets | £359.5k | £416.0k |
| Cash | £4.1k | £52.0k |
| Debtors | £235.4k | £245.6k |
| Net assets | £405.1k | £418.8k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
Corporate timeline (28 events)Click to expand
- 2025-12-22📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-01-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-09-26📄change-person-director-company-with-change-dateofficers · CH01
- 2024-09-26📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-12-08📄gazette-filings-brought-up-to-dategazette · DISS40
- 2023-11-21📄gazette-notice-compulsorygazette · GAZ1
- 2023-06-08📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-05-23➖MACPHERSON, Fionna resigneddirector
- 2023-05-23📄termination-director-company-with-name-termination-dateofficers · TM01
- 2022-10-04📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-07-13📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-09-03📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-09-12📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-08-30📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2017-09-15📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2016-06-16📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2016-06-01➕THOMPSON, Dawn Louise appointedsecretary
- 2016-06-01➕THOMPSON, Dawn Louise appointeddirector
- 2016-06-01➖THOMPSON, David resignedsecretary
- 2002-02-26🔒Charge registered #1Lender: The Royal Bank of Scotland PLC
- 2001-09-05🏢Company incorporatedAs ARRAN PHARMACY LIMITED
- 2001-09-05➕THOMPSON, David appointeddirector
- 2001-09-05➕THOMPSON, David appointedsecretary
- 2001-09-05➕OSWALDS OF EDINBURGH LIMITED appointedcorporate-nominee-secretary
- 2001-09-05➖OSWALDS OF EDINBURGH LIMITED resignedcorporate-nominee-secretary
- 2001-09-05➕MACPHERSON, Fionna appointeddirector
- 2001-09-05➕JORDANS (SCOTLAND) LIMITED appointedcorporate-nominee-director
- 2001-09-05➖JORDANS (SCOTLAND) LIMITED resignedcorporate-nominee-director
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Long-tenure founder: Senior director has been in place 25 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 72 — succession pressure is live.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 70+: Senior director is approximately 72 years old. Natural succession window is now.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- primary20+ year tenure: Director in role 25 years. Very long tenure is a classic succession signal.
- secondaryStable-but-static management: Company is 25 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr David Thomson Individual · British · DOB 10/1954 · age 72 | 75–100% | — | 75-100% shares | 05/09/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| OPTICAL EXPRESS LIMITED→ SC161469 · est 1995 | £80.82M £58.19M–£103.45M | — | — | 54900 | 30y | 85 | 58y |
| GP MATTERS LIMITED→ SC424457 · est 2012 | £3.46M £2.49M–£4.43M | — | — | 500 | 14y | 85 | 61y |
| ASPIRE HOUSING & PERSONAL DEVELOPMENT SERVICES LIMITED→ SC231773 · est 2002 | — | — | £354.7k | — | 24y | 83 | 77y |
| BCERTA LTD.→ SC355831 · est 2009 | — | — | — | — | 17y | 83 | 67y |
| COMMONWEALTH DENTAL PRACTICE LTD.→ SC381148 · est 2010 · no financials extracted | — | — | — | — | 15y | 83 | 58y |
| DAVID LIVINGSTONE INTERNATIONAL LIMITED→ SC118899 · est 1989 | — | — | £150.4k | — | 36y | 83 | 90y |
| DOON CARE LTD.→ SC262088 · est 2004 | — | — | £1.46M | — | 22y | 83 | 87y |
| DUNDONALD HOUSE NURSING HOME LIMITED→ SC296431 · est 2006 | — | — | — | — | 20y | 83 | 64y |
| FORWARD STEPS NURSERY LTD.→ SC235287 · est 2002 | — | — | £107.9k | — | 23y | 83 | 59y |
| MORNINGSIDE CAREHOMES (SCOTLAND) LTD.→ SC306303 · est 2006 | — | — | — | 7000 | 19y | 83 | 75y |
| THE GALGAEL TRUST→ SC246912 · est 2003 | — | — | £325.7k | — | 23y | 83 | 82y |
| THE SCOTTISH SPINA BIFIDA ASSOCIATION→ SC213050 · est 2000 · no financials extracted | — | — | — | — | 25y | 83 | 77y |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 4 resigned)
Click a director name to see their full track record across all companies.
Mortgages & charges
| Type | Properties | |||||
|---|---|---|---|---|---|---|
| outstanding | Lloyds Banking Group The Royal Bank of Scotland PLC | Bond & floating charge | 1 property | 26/02/2002 | — |